PRNewsWire
12 Jun 2026, 21:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
A securities fraud class action lawsuit has been filed against Regencell Bioscience Holdings Limited (NASDAQ: RGC). — Lawsuits alleging securities fraud typically trigger negative investor sentiment and can lead to significant legal liabilities.
-0.60The lawsuit alleges that Regencell was vulnerable to market manipulation and failed to disclose the associated financial risks to investors. — Claims of market manipulation and lack of transparency regarding volatility suggest systemic risk and poor corporate governance.
-0.50The litigation claims Regencell faced a heightened risk of regulatory scrutiny and governmental enforcement actions. — Potential government enforcement actions can result in heavy fines and operational restrictions.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is the subject of a securities fraud class action lawsuit alleging false and misleading statements.
The company is mentioned as being subject to a securities fraud class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
1h ago
